Dynavax Total Other Income Expense Net from 2010 to 2024

DVAX Stock  USD 12.36  0.19  1.56%   
Dynavax Technologies Total Other Income Expense Net yearly trend continues to be fairly stable with very little volatility. Total Other Income Expense Net is likely to outpace its year average in 2024. During the period from 2010 to 2024, Dynavax Technologies Total Other Income Expense Net regression line of annual values had r-squared of  0.02 and arithmetic mean of (1,603,197). View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2001-12-31
Previous Quarter
8.8 M
Current Value
9.7 M
Quarterly Volatility
10.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of Dynavax Technologies over the last few years. It is Dynavax Technologies' Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Pretty Stable
   Total Other Income Expense Net   
       Timeline  

Dynavax Total Other Income Expense Net Regression Statistics

Arithmetic Mean(1,603,197)
Geometric Mean2,534,631
Coefficient Of Variation(1,354)
Mean Deviation12,358,936
Median(293,000)
Standard Deviation21,713,271
Sample Variance471.5T
Range91.3M
R-Value0.13
Mean Square Error498.6T
R-Squared0.02
Significance0.63
Slope652,923
Total Sum of Squares6600.5T

Dynavax Total Other Income Expense Net History

202434.3 M
202332.7 M
202210.8 M
2021-57 M
2020-6.9 M
2019-31.1 M
2018-70 K

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Other Income Expense Net32.7 M34.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.